UNAIDS, 90-90-90: an ambitious treatment target to help end the AIDS epidemic. 2014, Joint United Nations Progamme on HIV/AIDS: Geneva, Switzeland. Available at https://www.unaids.org/en/resources/documents/2017/90-90-90. Accessed 14 July 2020.
Quinn TC, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342(13):921–9.
Grinsztejn B, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. 2014;14(4):281–90.
Nachega JB, et al. Achieving Viral Suppression in 90% of People Living With Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities. Clin Infect Dis. 2018;66(10):1487–91.
Stover J, et al. What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach. PLoS One. 2016;11(5):e0154893.
Bekker LG, et al. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet. 2018;392(10144):312–58.
Charles B, Lalthanmawia R. Providing HIV treatment closer to patient’s homes compared to more centralised treatment. Clin Epidemiol Global Health. 2013;1(2):94–5.
Kredo T, et al. Decentralising HIV treatment in lower- and middle-income countries. Cochrane Database Syst Rev. 2013;(6):Cd009987.
Suthar AB, et al. Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization. AIDS. 2014;28(Suppl 2):S175-85.
UNAIDS, Global HIV & AIDS statistics – 2020 Fact Sheet 2020, Joint United Nations Programme on HIV and AIDS: Geneva, Swizerland. Available at https://www.unaids.org/en/resources/fact-sheet. Accessed 10 July 2020.
UNAIDS, How AIDS changed everything—MDG6: 15 years, 15 lessons of hope from the AIDS response. 2015, Joint United Nations Programme on HIV and AIDS Geneva. Switzerland. Available at https://www.unaids.org/en/resources/documents/2015/MDG6_15years-15lessonsfromtheAIDSresponse. Accessed 20 Dec 2019.
Mutevedzi PC, et al. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ. 2010;88(8):593–600.
Boyer S, et al. Performance of HIV care decentralization from the patient’s perspective: health-related quality of life and perceived quality of services in Cameroon. Health Policy Plan. 2012;27(4):301–15.
Abongomera G, et al. Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and Uganda. Int Health. 2018;10(1):8–19.
Haakenstad A, et al. Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study. Lancet HIV. 2019;6(6):e382–95.
Resch S, Ryckman T, Hecht R. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries. Lancet Glob Health. 2015;3(1):e52-61.
Roberts T, et al. Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges. Clin Infect Dis. 2016;62(8):1043–8.
Pham MD, et al. Feasibility of antiretroviral treatment monitoring in the era of decentralized HIV care: a systematic review. AIDS Res Ther. 2017;14(1):3.
Marsh K, et al. Global, regional and country-level 90-90-90 estimates for 2018: assessing progress towards the 2020 target. AIDS. 2019;33(Suppl 3):S213–26.
Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
WHO, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendation for a public health approach - Second edition. 2016, The World Health Organization: Geneva, Switzerland. Available at https://www.who.int/hiv/pub/arv/arv-2016/en/. Accessed 20 Sept 2021.
Iwuji CC, et al. Clinical outcomes after first-line HIV treatment failure in South Africa: the next cascade of care. HIV Med. 2020;21(7):457–62.
Kehoe K, et al. Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis. J Int AIDS Soc. 2020;23(5):e25476.
Le Roux KW, et al. A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa. AIDS Patient Care & Stds. 2019;33(11):466–472.
Euvrard J, et al. How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa? South Afr Med J Suid-Afrikaanse Tydskrif Vir Geneeskunde. 2019;109(3):174–7.
Copelyn J, et al. Short-term outcomes of down-referral in provision of paediatric antiretroviral therapy at Red Cross War Memorial Children’s Hospital, Cape Town, South Africa: A retrospective cohort study. South Afr Med J Suid-Afrikaanse Tydskrif Vir Geneeskunde. 2018;108(5):432–8.
Tsondai PR, et al. High rates of retention and viral suppression in the scale-up of antiretroviral therapy adherence clubs in Cape Town, South Africa. J Int AIDS Soc. 2017;20(Suppl 4):21649.
Haghighat R, et al. The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study. BMC Infect Dis. 2021;21(1):60.
Woldesenbet SA, et al. Coverage of maternal viral load monitoring during pregnancy in South Africa: Results from the 2019 national Antenatal HIV Sentinel Survey. HIV Med. 2021;22(9):805–15. https://doi.org/10.1111/hiv.13126. Epub 2021 Jul 1.
Mshweshwe-Pakela N, et al. Feasibility of implementing same-day antiretroviral therapy initiation during routine care in Ekurhuleni District, South Africa: Retention and viral load suppression. South Afr J HIV Med. 2020;21(1):1085.
Sunpath H, et al. Targeting the third ‘90’: introducing the viral load champion. Public Health Action. 2018;8(4):225–31.
Moyo F, et al. Near-real-time tracking of gaps in prevention of mother-to-child transmission of HIV in three districts of KwaZulu-Natal Province, South Africa. S Afr Med J. 2018;108(4):319–24.
Tapera T, et al. Effects of a Peer-Led Intervention on HIV Care Continuum Outcomes Among Contacts of Children, Adolescents, and Young Adults Living With HIV in Zimbabwe. Glob Health Sci Pract. 2019;7(4):575–84.
Nyakura J, et al. Viral load testing among women on ‘option B+’ in Mazowe, Zimbabwe: How well are we doing? PLoS One. 2019;14(12):e0225476.
Nyagadza B, et al. Scaling up HIV viral load monitoring in Manicaland, Zimbabwe: challenges and opportunities from the field. Public Health Action. 2019;9(4):177–81.
Apollo T, et al. Provision of HIV viral load testing services in Zimbabwe: Secondary data analyses using data from health facilities using the electronic Patient Monitoring System. PLoS One. 2021;16(1):e0245720.
Ndagijimana Ntwali JD, et al. Viral load detection and management on first line ART in rural Rwanda. BMC Infect Dis. 2019;19(1):8.
Cyamatare Rwabukwisi F, et al. Five-year Outcomes Among Children Receiving Antiretroviral Therapy in a Community-based Accompaniment Program in Rural Rwanda. Pediatr Infect Dis J. 2016;35(11):1222–4.
Amzel A, et al. Community-Based Interventions to Reach 95-95-95 for Children and Adolescents: An Exploratory Programmatic Review From Lesotho. J Acquired Immune Deficiency Syndromes. 2018;78(Suppl 2):S81–7.
Etoori D, et al. Challenges and successes in the implementation of option B + to prevent mother-to-child transmission of HIV in southern Swaziland. BMC Public Health. 2018;18(1):374.
Cisse AM, et al. High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal. BMC Pediatr. 2019;19(1):47.
Nicholas S, et al. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi. J Int AIDS Soc. 2019;22(8):e25387.
Moudachirou R, et al. Retention and sustained viral suppression in HIV patients transferred to community refill centres in Kinshasa, DRC. Public Health Action. 2020;10(1):33–7.
Kadima J, et al. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya. PLoS One. 2018;13(11):e0200242.
Swannet S, et al. Journey towards universal viral load monitoring in Maputo, Mozambique: many gaps, but encouraging signs. Int Health. 2017;9(4):206–14.
Namale G, et al. Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study. Sex Transm Infect. 2019;95(6):405–11.
Nakalega R, et al. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda. BMC Infect Dis. 2020;20(1):727.
Opito R, et al. Treatment outcome of the implementation of HIV test and treat policy at The AIDs Support Organization (TASO) Tororo clinic, Eastern Uganda: A retrospective cohort study. PLoS One. 2020;15(9):e0239087.
Brazier E, et al. Effects of national adoption of Treat-All guidelines on pre-ART CD4 testing and viral load monitoring after ART initiation: A regression discontinuity analysis. Clin Infect Dis. 2021;73(6):e1273–e1281. https://doi.org/10.1093/cid/ciab222.
Herce ME, et al. Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study. Lancet HIV. 2020;7(12):e807–16.
Kyaw NT, et al. High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005–2015. PLoS One. 2017;12(2):e0171780.
Thinn KK, et al. Uptake of routine viral load testing among people living with HIV and its implementation challenges in Yangon region of Myanmar: a mixed-methods study. BMJ Open. 2019;9(12):e032678.
Ya SST, et al. Performance and Outcomes of Routine Viral Load Testing in People Living with HIV Newly Initiating ART in the Integrated HIV Care Program in Myanmar between January 2016 and December 2017. Trop Med Infect Dis. 2020;5(3):140. https://doi.org/10.3390/tropicalmed5030140.
Januraga PP, et al. The cascade of HIV care among key populations in Indonesia: a prospective cohort study. Lancet HIV. 2018;5(10):e560–8.
Nguyen TA, et al. Feasibility of dried blood spots for HIV viral load monitoring in decentralized area in North Vietnam in a test-and-treat era, the MOVIDA project. PLoS One. 2020;15(4):e0230968.
Ehrenkranz PD, et al. The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings. PLoS Med. 2019;16(5):e1002820.
Carmona S, Peter T, Berrie L. HIV viral load scale-up: multiple interventions to meet the HIV treatment cascade. Curr Opin HIV AIDS. 2017;12(2):157–64.
Han WM, et al. Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. Lancet HIV. 2021;8(12):e766–75.
Sandbulte M, et al. Maternal viral load monitoring: Coverage and clinical action at 4 Kenyan hospitals. PLoS One. 2020;15(5):e0232358.
Yotebieng M, et al. HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study. J Int AIDS Soc. 2019;22(9):e25376.
Cote AM, et al. Transactional sex is the driving force in the dynamics of HIV in Accra, Ghana. AIDS. 2004;18(6):917–25.
Huerga H, et al. Higher risk sexual behaviour is associated with unawareness of HIV-positivity and lack of viral suppression - implications for Treatment as Prevention. Sci Rep. 2017;7(1):16117.
Vaz P, et al. Compromise of Second-Line Antiretroviral Therapy Due to High Rates of Human Immunodeficiency Virus Drug Resistance in Mozambican Treatment-Experienced Children With Virologic Failure. J Pediatric Infect Dis Soc. 2020;9(1):6–13.
Kantor R, et al. HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya. AIDS. 2018;32(17):2485–96.
Pennings PS. HIV Drug Resistance: Problems and Perspectives. Infect Dis Rep. 2013;5(Suppl 1):e5.
Labhardt ND, et al. When patients fail UNAIDS’ last 90 - the “failure cascade” beyond 90-90-90 in rural Lesotho, Southern Africa: a prospective cohort study. J Int AIDS Soc. 2017;20(1):21803.
Etoori D, et al. Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland. J Int AIDS Soc. 2018;21(10):e25194.
Glass TR, et al. The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho. PLoS One. 2019;14(8):e0220337.
Ford N, et al. HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis. J Int AIDS Soc. 2019;22(11):e25415.
Smit PW, et al. Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One. 2014;9(3):e86461.
WHO, Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: Recommendation for a public health approach. 2021, The World Health Organization: Geneva, Switzerland. Available at https://www.who.int/publications/i/item/9789240031593. Accessed 30 Mar 2022.
WHO, HIV molecular diagnostics toolkit to improve access to viral load testing and infant diagnosis. 2019, The World Health Organization: Geneva, Switzerland. Available at https://www.who.int/publications/i/item/9789241516211. Accessed 30 Mar 2022.
Pham MD, et al. Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study. J Clin Microbiol. 2019;57(4):e01683–18. https://doi.org/10.1128/JCM.01683-18. Print 2019 Apr.
Carmona S, et al. Separation of Plasma from Whole Blood by Use of the cobas Plasma Separation Card: a Compelling Alternative to Dried Blood Spots for Quantification of HIV-1 Viral Load. J Clin Microbiol. 2019;57(4):e01336–18. https://doi.org/10.1128/JCM.01336-18. Print 2019 Apr.
Estill J, et al. The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study. Lancet HIV. 2016;3(3):e132-9.
Eholie SP, et al. Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study. Lancet HIV. 2019;6(11):e750–9.